Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Trading Update

26 Oct 2022 07:00

RNS Number : 0992E
React Group PLC
26 October 2022
 

 

26 October 2022

REACT Group plc

("REACT", the "Group" or the "Company")

Trading Update

REACT Group plc (AIM:REAT.L), the leading specialist cleaning, hygiene and decontamination company is pleased to announce a trading update in respect of the year ended 30 September 2022 ("FY22").

In our interim results, announced on 30 June 2022, we reported a strong start to the second half of FY22 ("H2") with LaddersFree, acquired on 12 May 2022, performing in line with management expectations and that the outlook for the Group as a whole remained positive.

The Group continued to make good progress in H2. The LaddersFree performance has been strong, underpinned by multiple new contract wins in the schools and colleges, and commercial sectors. A key feature of these contracts is that they have the potential for the Company to extend the range of services to customers and provide the Group with additional recurring income.

Fidelis, our hygiene and maintenance division, has also performed well and has been a significant contributor to EBITDA for the full year. In order to better position and facilitate additional anticipated growth in Fidelis and across the wider Group, the Group has stepped up its capacity and taken on increased overheads through additional operations and senior sales and marketing hires. Whilst this has increased costs during the year, and therefore impacted EBITDA margin, the investment has already, and is continuing to have, a positive impact with increased sales momentum particularly with small to medium sized contract wins and a growing pipeline of potential new contracts across the Group.

Performance in our emergency and decontamination division, React, where contracts are higher margin and tend to be more one-off and reactive, is still in the process of returning to normal levels following the end of lockdown measures and changes in working practices arising from this. Despite slower than expected growth in this division in FY22, performance has shown an improvement with increasing revenues generated in this division and a particularly strong Q4 which has persisted into the start of the current financial year.

Subject to audit, revenues for the year ended 30 September 2022 are expected to be approximately £13.6 million (FY22 market forecast: £13.6m) (30 September 2021: £7.1 million) with Adjusted EBITDA* of approximately £1.0 million (FY22 market forecast: £1.3m) (30 September 2021: £0.79 million). The Group's balance sheet remains strong, the Company's cash balance on 30 September 2022 was approximately £1.53 million (30 September 2021: £0.57 million). In addition to the cash balance in the bank, the Company has an ID facility of £2.0 million, against which it had drawn down £0.5 million on 30 September 2022 and a 5-year term loan of £1.0 million.

*adjusted for exceptional items relating to the acquisition of LaddersFree, Fidelis and investigating other potential acquisition targets, as well as costs associated with the new loan facility.

Trading in the last three months of the year ended 30 September 2022, and into the current financial year, has been especially strong across the Group, with all divisions continuing to win a broad spread of business providing the positive margin contribution and cash generation we are seeking. This positive start underpins the Board's optimistic outlook for the current financial year.

The Board also provides a further update on the deferred consideration payable in cash to the vendors of Fidelis. During the year to 31 March 2022, Fidelis generated revenue of £6.6 million, gross profit of £1.5 million and EBITDA of £0.5 million. As such, the Board now anticipates the maximum deferred consideration payable, including associated acquisition costs due to advisers, will be up to approximately £0.3 million and will be made in four equal instalments between October 2022 and March 2024.

 Commenting on the trading update Shaun Doak, Chief Executive Officer of REACT, said:

"Our cautious but positive outlook following H1 proved to be an accurate assessment of H2 performance in our Fidelis and React divisions, although in both cases Q4 performance has shown good growth which has continued so far in the current financial year. LaddersFree has performed particularly well since acquisition and has seen a number of new contract wins. The nature of these contracts provides us with both recurring income and potential to provide ancillary services. Despite the volatile macro-economic domestic and international background, the markets we are addressing are large and fragmented, providing significant opportunities for growth. We remain confident that the high quality services the Group provides will continue to be very much in demand and that we will meet our growth expectations for the current year."

 

For more information:

REACT Group Plc

Shaun Doak, Chief Executive Ofcer

Andrea Pankhurst, Chief Financial Officer

Mark Braund, Chairman

Tel: +44 (0) 1283 550 503

 

Singer Capital Markets

(Nominated Adviser / Broker)

 

Will Goode / Amanda Gray (Corporate Finance)

Rachel Hayes (Corporate Broking)

Tel: +44 (0) 207 496 3000

 

IFC Advisory

(Financial PR / IR)

Graham Herring / Zach Cohen

 

Tel: +44 (0) 20 3934 6630

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"). Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAEESAAKAFAA
Date   Source Headline
20th Apr 20204:41 pmRNSSecond Price Monitoring Extn
20th Apr 20204:36 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSTrading Update
16th Mar 20204:43 pmRNSSecond Price Monitoring Extn
16th Mar 20204:38 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSBoard Appointment
26th Feb 202011:13 amRNSResult of AGM
26th Feb 20207:00 amRNSAGM Statement
3rd Feb 20207:00 amRNSContract Award
30th Jan 20207:00 amRNSPublication of 2019 Report & Accounts
23rd Jan 20207:00 amRNSMaterial Contract Award
4th Dec 201910:50 amRNSHolding(s) in Company
24th Oct 20197:00 amRNSPost year end trading update
11th Oct 20198:17 amRNSHolding(s) in Company
10th Oct 20199:41 amRNSHolding(s) in Company
30th Sep 20191:48 pmRNSTR-1: Notification of major holdings
23rd Sep 201911:21 amRNSHolding(s) in Company
28th Jun 20197:00 amRNSInterim Results
17th May 201912:39 pmRNSGrant of Options and Warrants
14th Mar 201910:42 amRNSDirector/PDMR Shareholding
13th Mar 20195:08 pmRNSDirector/PDMR Shareholding
12th Mar 201912:30 pmRNSResult of AGM
8th Mar 20197:00 amRNSDirectorate Change
6th Mar 20191:13 pmRNSTR-1: Notification of major holdings
21st Feb 20193:39 pmRNSNotice of AGM - Clarification
18th Feb 20197:00 amRNSSenior Management Appointment
15th Feb 20197:00 amRNSFinal Results
18th Jan 20191:08 pmRNSBoard Change
20th Dec 20182:43 pmRNSTR-1: Notification of major holdings
27th Nov 20181:01 pmRNSUpdate
1st Nov 20187:00 amRNSDirectorate Change
31st Aug 201811:48 amRNSResult of Meeting
14th Aug 20187:00 amRNSPlacing to raise £420k; Notice of General Meeting
22nd Jun 20187:00 amRNSINTERIM RESULTS FOR 6 MONTHS ENDED 31 MARCH 2018
24th May 20182:54 pmRNSChange of Registered Office
22nd May 20181:40 pmRNSAddl contract with major highways construction co
2nd May 20187:00 amRNSAppointment of Interim Head of Operations
18th Apr 20187:00 amRNSWithdrawal of AGM Resolution
11th Apr 20187:00 amRNSHolding(s) in Company
6th Apr 20188:45 amRNSDirectorate Change
3rd Apr 20187:00 amRNSNotice of AGM
28th Mar 20181:49 pmRNSDirectorate Change
27th Mar 20187:00 amRNSFinal Results
2nd Mar 20187:00 amRNSAdditional Contract win with Major LondonHospital
13th Feb 20187:00 amRNSDirectorate Change
24th Jan 20184:08 pmRNSAppointment of Joint Broker
17th Jan 20182:56 pmRNSTR-1:Notification of major holdings
16th Jan 20185:06 pmRNSHolding(s) in Company
16th Jan 20188:55 amRNSHolding(s) in Company
16th Jan 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.